Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 509

Results For "Inc"

5361 News Found

Combinations of Sputnik V component with other vaccines demonstrate favourable results: RDIF
Drug Approval | August 05, 2021

Combinations of Sputnik V component with other vaccines demonstrate favourable results: RDIF

AstraZeneca, Sinopharm and Moderna were part of the study


Aartas launches co-working space for doctors under Clinishare
Healthcare | August 04, 2021

Aartas launches co-working space for doctors under Clinishare

Startup receives US $ 5 million in first round of funding


Illumina donates US $ I million in sequencing capabilities to BMC in Mumbai
Healthcare | August 04, 2021

Illumina donates US $ I million in sequencing capabilities to BMC in Mumbai

It supports sequencing-based COVID 19 surveillance in India


India Initiates anti dumping probe against import of ATS-8 from China
Policy | August 04, 2021

India Initiates anti dumping probe against import of ATS-8 from China

Arch Pharma Labs has filed the application


Govt committed to recognise healthcare workers engaged in Covid-19
Policy | August 04, 2021

Govt committed to recognise healthcare workers engaged in Covid-19

Five seats reserved for Wards of COVID warriors in central MBBS admission


Wipro GE Healthcare introduces remote monitoring solution for COVID 19
Healthcare | August 04, 2021

Wipro GE Healthcare introduces remote monitoring solution for COVID 19

Apollo hospital-Hyderabad, Kainos Hospital-Rohtak and Apex Hospital Jaipur have deployed this solution


Solara Active Pharma Science clocks net profit of Rs 50.13 crore in Q1FY22
News | August 04, 2021

Solara Active Pharma Science clocks net profit of Rs 50.13 crore in Q1FY22

Aditya Puri former MD of HDFC bank joins Solara board as chairman


Mindpeers launches on-demand behavioural healthcare platform
Healthcare | August 04, 2021

Mindpeers launches on-demand behavioural healthcare platform

It is designed to tackle mental health issues


PLI Scheme to generate export potential of Rs 196,000 crore by 2027 : Mandaviya
Policy | August 03, 2021

PLI Scheme to generate export potential of Rs 196,000 crore by 2027 : Mandaviya

The scheme incentivizes the manufacturing of patented drugs and other high value drugs at an incentive rate of 10% of incremental sales


Evexia Lifecare to manufacture API of Isometa
News | August 03, 2021

Evexia Lifecare to manufacture API of Isometa

Robust demand for the product across the Middle East, Africa and Latin America